The need for development of other enterovirus vaccines in addition to EV-A71 vaccine
Saved in:
| Main Authors: | Daoyan Xu, Jian Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2340854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges to licensure of enterovirus 71 vaccines.
by: Min-Shi Lee, et al.
Published: (2012-01-01) -
Cost-effectiveness of a national enterovirus 71 vaccination program in China.
by: Wenjun Wang, et al.
Published: (2017-09-01) -
Enterovirus A71 priorities, challenges, and future opportunities in humoral immunity and vaccine development
by: Amanda Makha Bifani, et al.
Published: (2025-08-01) -
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
by: Shi-Hsia Hwa, et al.
Published: (2013-11-01) -
Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates
by: Ai-Hsiang Chou, et al.
Published: (2012-01-01)